title: Dysferlin is a newly identified binding partner of AβPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers.
authors.affiliation: Department of Neurology, USC Neuromuscular Center, Good Samaritan Hospital, University of Southern California Keck School of Medicine, 637 S. Lucas Ave, Los Angeles, CA, 90017-1912, USA.
authors.forename: Mafalda
authors.initials: M
authors.lastname: Cacciottolo
authors.forename: Anna
authors.initials: A
authors.lastname: Nogalska
authors.forename: Carla
authors.initials: C
authors.lastname: D'Agostino
authors.forename: W King
authors.initials: WK
authors.lastname: Engel
authors.forename: Valerie
authors.initials: V
authors.lastname: Askanas
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000073939:Dysferlin; D005455:Fluorescent Antibody Technique; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism*; D009124:Muscle Proteins / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000378:metabolism* / Q000473:pathology; D018979:Myositis, Inclusion Body / Q000378:metabolism* / Q000473:pathology
chemical_list: D016229:Amyloid beta-Peptides; C114839:DYSF protein, human; D000073939:Dysferlin; D008565:Membrane Proteins; D009124:Muscle Proteins